China’s U.S. IPO Queue to Shrink Amid Regulatory Crackdown
- Broadened scrutiny by Beijing particularly bad for small firms
- ByteDance said to have met with officials over data security
This article is for subscribers only.
China’s crackdown on U.S. initial public offerings by its companies has put its burgeoning pipeline of potential listings at risk.
A medical data company, a fitness app and an e-commerce platform have, in the past week, postponed plans to go public in the U.S., as Beijing cracks down on tech and data-heavy firms listing stateside. There are about 70 other private firms based in Hong Kong and China set to go public in New York, according to data compiled by Bloomberg.